Skip to main content
. 2021 Oct 8;10(20):e021150. doi: 10.1161/JAHA.120.021150

Table 2.

Presentation Characteristics Stratified by Center Volume

Low‐volume center

(n=537, 52%)

Intermediate‐volume center

(n=240, 23%)

High‐volume center

(n=255, 25%)

Coronary artery characteristics
Number of diseased vessels
Single‐vessel disease 76 (14.3) 34 (14.5) 27 (10.9)
Double‐vessel disease 171 (32.3) 68 (28.9) 75 (30.4)
Triple‐vessel disease 283 (53.4) 133 (56.6) 145 (58.7)
Coronary artery with culprit lesion
RCA 154 (29.1) 62 (26.7) 68 (27.6)
Left main 51 (9.6) 14 (6.0) 16 (6.5)
LAD 214 (40.4) 108 (46.6) 113 (45.9)
CFX 102 (19.2) 46 (19.8) 48 (19.5)
CABG 9 (1.7) 2 (0.9) 1 (0.4)
TIMI‐flow pre‐PCI (culprit lesion)
0 262 (50.5) 147 (62.6) 154 (63.4)
1 68 (13.1) 26 (11.1) 28 (11.5)
2 92 (17.7) 21 (8.9) 37 (15.2)
3 97 (18.7) 41 (17.4) 24 (9.9)
Clinical characteristics
Mechanical ventilation 333 (63.2) 141 (59.5) 121 (52.6)
Fibrinolysis within 24 h 33 (6.3) 12 (5.0) 16 (7.0)
Resuscitation within 24 h 303 (57.5) 140 (58.8) 97 (42.2)
Systolic blood pressure, mm Hg 106 (±30) 106 (±32) 106 (±31)
Diastolic blood pressure, mm Hg 65 (±20) 65 (±23) 64 (±18)
Heart rate, bpm 91 (±27) 89 (±24) 93 (±28)
ST‐elevation or LBBB 375 (73.0) 174 (74.4) 159 (71.3)
Atrial fibrillation 63 (12.2) 22 (9.4) 37 (16.4)
Creatinine, μmol/L 111 (90, 141) 106 (88, 139) 116 (93, 149)
Arterial lactate, mmol/L 5.4 (2.7, 8.9) 5.2 (2.6, 8.7) 4.4 (2.6, 8.1)
Mechanical circulatory support 165 (30.7%) 88 (36.7%) 49 (19.2%)
IABP 70 (42.4%) 29 (33.0%) 21 (42.9%)
Impella 2.5 30 (18.2%) 12 (13.6%) 2 (4.1%)
Impella CP 37 (22.4%) 20 (22.7%) 11 (22.4%)
VA‐ECMO 35 (21.2%) 35 (39.8%) 23 (46.9%)
Other 4 (2.4%) 2 (2.3%) 0 (0%)

Bpm indicates beats per minute; CABG, coronary artery bypass graft; CFX, circumflex artery; IABP, intra‐aortic balloon pump; LAD, left anterior descending artery; LBBB, left bundle‐branch block; PCI, percutaneous coronary intervention; RCA, right coronary artery; TIMI, Thrombolysis in Myocardial Infarction; and VA‐ECMO, veno‐arterial extracorporeal membrane oxygenation therapy.